BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38683288)

  • 1. Correction: The public health impacts of supervised injection sites in Canada: Moving beyond social acceptability and impacts on crime.
    Côté-Lussier C; Rodrigues P
    Can J Public Health; 2024 Jun; 115(3):472. PubMed ID: 38683288
    [No Abstract]   [Full Text] [Related]  

  • 2. The public health impacts of supervised injection sites in Canada: Moving beyond social acceptability and impacts on crime.
    Côté-Lussier C; Rodrigues P
    Can J Public Health; 2024 Jun; 115(3):468-471. PubMed ID: 38602661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.
    Kennedy MC; Hayashi K; Milloy MJ; Compton M; Kerr T
    Addiction; 2022 Apr; 117(4):986-997. PubMed ID: 34854162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supervised consumption sites and crime: scrutinizing the methodological weaknesses and aberrant results of a government report in Alberta, Canada.
    Livingston JD
    Harm Reduct J; 2021 Jan; 18(1):4. PubMed ID: 33407533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised Injection Facilities as Harm Reduction: A Systematic Review.
    Levengood TW; Yoon GH; Davoust MJ; Ogden SN; Marshall BDL; Cahill SR; Bazzi AR
    Am J Prev Med; 2021 Nov; 61(5):738-749. PubMed ID: 34218964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV.
    Rudzinski K; Xavier J; Guta A; Chan Carusone S; King K; Phillips JC; Switzer S; O'Leary B; Baltzer Turje R; Harrison S; de Prinse K; Simons J; Strike C
    BMC Public Health; 2021 Jul; 21(1):1482. PubMed ID: 34325681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supervised injection services: what has been demonstrated? A systematic literature review.
    Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
    Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outside looking in: the community impacts of anti-lesbian, gay, and bisexual hate crime.
    Bell JG; Perry B
    J Homosex; 2015; 62(1):98-120. PubMed ID: 25153691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.
    Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH
    Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of Canada's cannabis legalization on police-reported crime among youth: early evidence.
    Callaghan RC; Vander Heiden J; Sanches M; Asbridge M; Hathaway A; Kish SJ
    Addiction; 2021 Dec; 116(12):3454-3462. PubMed ID: 34085338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supervised injection sites: Health Canada approves Vancouver pilot sites, but concerns remain.
    Kerr T
    Can HIV AIDS Policy Law Rev; 2003 Aug; 8(2):18-20. PubMed ID: 14746291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.
    Enns EA; Zaric GS; Strike CJ; Jairam JA; Kolla G; Bayoumi AM
    Addiction; 2016 Mar; 111(3):475-89. PubMed ID: 26616368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.
    Kennedy MC; Karamouzian M; Kerr T
    Curr HIV/AIDS Rep; 2017 Oct; 14(5):161-183. PubMed ID: 28875422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing public support for supervised injection facilities in Ontario, Canada.
    Strike C; Jairam JA; Kolla G; Millson P; Shepherd S; Fischer B; Watson TM; Bayoumi AM
    Addiction; 2014 Jun; 109(6):946-53. PubMed ID: 24520984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
    Wood E; Tyndall MW; Montaner JS; Kerr T
    CMAJ; 2006 Nov; 175(11):1399-404. PubMed ID: 17116909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).
    Fischer B; Rehm J; Brissette S; Brochu S; Bruneau J; El-Guebaly N; Noël L; Tyndall M; Wild C; Mun P; Baliunas D
    J Urban Health; 2005 Jun; 82(2):250-66. PubMed ID: 15872194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of tick control interventions to prevent Lyme disease in Switzerland and Canada: a mixed-method study.
    Aenishaenslin C; Michel P; Ravel A; Gern L; Waaub JP; Milord F; Bélanger D
    BMC Public Health; 2016 Jan; 16():12. PubMed ID: 26733007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ever-changing narrative: Supervised injection site policy making in Ontario, Canada.
    Ziegler BR; Wray AJ; Luginaah I
    Int J Drug Policy; 2019 Dec; 74():98-111. PubMed ID: 31586776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.